Global Insomnia Market Outlook, Trends And Future Opportunities (2024-2031)

Download FREE Sample Customize As Per Need Buy Now
  1. home
  2. Report Store
  3. Global Insomnia Market

Global Insomnia Market Outlook, Trends And Future Opportunities (2024-2031)

Global Insomnia Market, By Product Type (Prescription sleep medications, Over-the-counter sleep aids, Medical devices), By Insomnia Type (Chronic insomnia, Acute insomnia, Comorbid insomnia, Others), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies, Others), By Treatment (Pharmacological treatments, Non-pharmacological treatments (e.g., CBT, relaxation techniques), Others), By End User (Hospitals, Sleep centers, Clinics, Home care settings, Others), By Cause (Medical conditions (e.g., chronic pain, cancer), Psychiatric disorders (e.g., anxiety, depression), Substance abuse, Lifestyle factors (e.g., stress, jet lag), Hormonal imbalances, Others), Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) The report offers a comprehensive view of the market from supply as well as demand side to help take informed decisions.

  • Published On: Apr 2024
  • Author(s): Sagar Karlekar
  • Report ID: IDA139
  • Region: Global
  • Format: PDF/EXCEL
Press Release: Global Insomnia Market is Forecasted to Hit US$ 7.5 Bn By 2031 | CAGR 11.2%

Table Of Contents:

  • Chapter 1. Research Methodology and Scope
    • Market Segmentation and Scope
    • Regional Coverage
    • Objectives
    • Research Methodology
  • Chapter 2. Executive Summary
    • Market Landscape
    • Market Size & Forecast
    • Competitive Landscape
  • Chapter 3. Global Insomnia Market: By Product Type Segment Trends, Size, and Future Outlook
    • By Product Type Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Product Type Segment Definitions, Technology Landscape
    • By Product Type Segment Market Drivers
      • Product Launches
      • Technology Launches
    • By Product Type Segment Market Restraints
  • Chapter 4. Global Insomnia Market: By Insomnia Type Segment Trends, Size, and Future Outlook
    • By Insomnia Type Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Insomnia Type Segment Definitions, Technology Landscape
    • By Insomnia Type Segment Market Drivers
      • Product Launches
      • Technology Launches
    • By Insomnia Type Segment Market Restraints
  • Chapter 5. Global Insomnia Market: By Distribution Channel Segment Trends, Size, and Future Outlook
    • By Distribution Channel Segment Market Size (US$), CAGR (%), and Forecast (2021-2031)
    • By Distribution Channel Segment Definitions, Technology Landscape
    • By Distribution Channel Segment Market Drivers
      • Product Launches
      • Technology Launches
    • By Distribution Channel Segment Market Restraints
  • Chapter 6. Global Insomnia Market: Regional Market Trends, Size, and Future Outlook
    • North America
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
    • Europe
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
    • Asia Pacific
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
    • Latin America
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
    • Middle East, and Africa
      • Trends, Market Size (US$), CAGR (%), and Future Outlook
      • Market Size (US$), CAGR (%), and Forecast (2021-2031)
      • Definitions, Technology Landscape
      • Market Drivers
        • Product Launches
        • Technology Launches
      • Market Restraints
      • Competitive Outlook
  • Chapter 8. Global Insomnia Market: Competitive Landscape
    • Sanofi
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Merck & Co.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Pfizer Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Eisai Co., Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Idorsia Pharmaceuticals Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Minerva Neurosciences, Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Sumitomo Dainippon Pharma Co., Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Mylan N.V.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Teva Pharmaceutical Industries Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Lundbeck
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Vanda Pharmaceuticals Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Hisamitsu Pharmaceutical Co., Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Sunovion Pharmaceuticals Inc.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Alkermes plc
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Otsuka Holdings Co., Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Eli Lilly and Company
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • GlaxoSmithKline plc
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Dainippon Sumitomo Pharma Co., Ltd.
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
    • Novartis AG
      • Company Overview
      • Financial Outlook
      • Product Portfolio
      • Strategies
  • Research Methodology
    • Primary Research
    • Secondary Research
    • Assumptions
    • IDataAcumen Analysis
    • Paid Databases
  • Appendix
    • About Us

Frequently Asked Questions

The current market size of the Global Insomnia industry is USD 3.2 billion.

The key factors driving the growth of the Global Insomnia Market include increasing prevalence of insomnia, rising stress and anxiety levels, growing aging population, unhealthy lifestyle factors, development of novel insomnia drugs, adoption of digital therapeutics, increasing awareness and diagnosis, and expanding usage of wearable devices.

The key factors hampering the growth of the Global Insomnia Market include side effects of insomnia medications, high cost of treatment, lack of awareness in underdeveloped regions, and stringent regulatory guidelines.

The leading component segment in the Global Insomnia Market is the prescription sleep medications segment, which is used to treat insomnia effectively.

The major players operating in the Global Insomnia Market include Sanofi, Merck & Co., Pfizer Inc., Takeda Pharmaceutical Company Limited, Eisai Co., Ltd., Idorsia Pharmaceuticals Ltd., Minerva Neurosciences, Inc., Sumitomo Dainippon Pharma Co., Ltd., Mylan N.V., and Teva Pharmaceutical Industries Ltd.

The North America region is expected to lead the Global Insomnia Market, with a market share of 35.8% in 2023. The Global Insomnia Market is expected to grow at a CAGR of 11.2% from 2023 to 2031, reaching a market size of USD 7.5 billion by 2031.

The key drivers of the Global Insomnia Market include increasing prevalence of insomnia, rising stress and anxiety levels, growing aging population, development of novel insomnia drugs, and increasing awareness and diagnosis.
Download FREE Sample Buy Now